To substantiate the applicability of this model in other gynecologic malignancies, we also evaluated changes in ERα expression in the ERα-positive endometrial carcinoma cell line, Ishikiawa (Fig. S2). The gene discussed is ESR1; the disease is endometrial carcinoma.